News Releases - Achieve Life Sciences
HOME
ABOUT ACHIEVE
About Achieve
Management Team
Board of Directors
PRODUCTS
Cytisinicline
NEWS
Press Releases
Events
Blog
INVESTORS
CONTACT
HOME
ABOUT ACHIEVE
About Achieve
Senior Management
PRODUCTS
Cytisinicline
NEWS
INVESTORS
CONTACT
News Releases
Home
/
News Releases
Home
ivps4
2017-06-16T21:39:52+00:00
Investors Home
Corporate Governance
News Releases
Financial Information
SEC Filings
Events and Webcasts
Investor Contacts
Investor Alerts
NASDAQ: ACHV
NASDAQ: OGXI
News Releases
Investor Alerts
Year
All Years
2021
2020
2019
2018
2017
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Photos
Video
Audio
Documents
Events
Standard
Mar 13, 2020
Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program
Mar 12, 2020
Achieve Life Sciences Announces Presentation of Additional Cytisinicline Analyses at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting
Mar 3, 2020
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2019 Financial Results and Host Conference Call and Webcast on March 13, 2020
Feb 6, 2020
Achieve Life Sciences Announces Agreement with the FreeMind Group to Assist in Securing Non-Dilutive Funding to Evaluate Cytisinicline in Vaping and e-Cigarette Users
Jan 13, 2020
Achieve Life Sciences, University of Bristol, and Oracle Corporation Announce Study Results Demonstrating Potential for Accelerated Speed of Drug Discovery
Show
5
10
25
50
100
per page
«
1
2
3
4
5
6
7
8
9
…
20
»
NASDAQ: ACHV
NASDAQ: OGXI
1dy
1mo
6mo
1yr
5yr
Stock Info
NASDAQ: ACHV
NASDAQ: OGXI
Go to Top